TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/24 20:00 | 6/26/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S | -26 | 4.75 | 0 | -5 | -6 | 84 | D | ||||||||||||||
6/3/24 20:00 | 5/31/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S | -12 | 6.09 | 0 | -2 | -2 | 89 | D | ||||||||||||||
1/5/24 16:05 | 1/4/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S.d | -11 | 6.74 | 0 | -2 | -2 | 91 | D | ||||||||||||||
1/6/23 20:00 | 1/4/23 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S | -2 | 28.53 | 0 | 0 | 0 | 19 | D | ||||||||||||||
10/28/22 16:15 | 10/26/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S | -2 | 6.51 | 0 | 0 | -4 | 6 | D | ||||||||||||||
6/29/22 20:11 | 6/27/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | S | -1 | 0.3700 | 0 | -3 | -1 | 285 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |